Presentation Information
[S-03-1]Impact of early fast-acting treatment in myasthenia gravis
Akiyuki Uzawa (Graduate School of Medicine, Chiba University, Japan)
CAREER
2003-2005 Department of Neurology, Chiba University Hospital
2005-2006 Department of Neurology, Chiba Municipal Aoba Hospital
2006-2007 Department of Neurology, Chiba Rosai Hospital
2007-2008 Department of Neurology, Matsudo Municipal Hospital
2008- Department of Neurology, Chiba University Hospital
SPECIALITY
Neuroimmunology (myasthenia gravis; multiple sclerosis; neuromyelitis optica)
Editorial committee member of Japanese clinical guidelines 2022 for myasthenia gravis and Lambert-Eaton myasthenic syndrome
AWARDS
2022 Japanese Society for Neuroimmunology, Research and Creation Award
2022 Japanese Society of Neurological Therapeutics, Therapeutic Academic Award
2022 Best Oral Presentation Award, Japanese Society of Neurological Therapeutics
2018 Best Oral Presentation Award, Japanese Society of Neurology
2012 Asian Oceanian Congress of Neurology, Young Investigator Encouragement
2003-2005 Department of Neurology, Chiba University Hospital
2005-2006 Department of Neurology, Chiba Municipal Aoba Hospital
2006-2007 Department of Neurology, Chiba Rosai Hospital
2007-2008 Department of Neurology, Matsudo Municipal Hospital
2008- Department of Neurology, Chiba University Hospital
SPECIALITY
Neuroimmunology (myasthenia gravis; multiple sclerosis; neuromyelitis optica)
Editorial committee member of Japanese clinical guidelines 2022 for myasthenia gravis and Lambert-Eaton myasthenic syndrome
AWARDS
2022 Japanese Society for Neuroimmunology, Research and Creation Award
2022 Japanese Society of Neurological Therapeutics, Therapeutic Academic Award
2022 Best Oral Presentation Award, Japanese Society of Neurological Therapeutics
2018 Best Oral Presentation Award, Japanese Society of Neurology
2012 Asian Oceanian Congress of Neurology, Young Investigator Encouragement